Filing Details
- Accession Number:
- 0001237899-13-000034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-14 11:51:49
- Reporting Period:
- 2013-05-10
- Filing Date:
- 2013-05-14
- Accepted Time:
- 2013-05-14 11:51:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Research And Development S | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-10 | 55,438 | $21.92 | 104,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-10 | 4,527 | $268.40 | 99,899 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-05-10 | 27,873 | $268.40 | 72,026 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-05-13 | 13,378 | $276.71 | 58,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-05-13 | 9,660 | $277.12 | 48,988 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-05-10 | 55,438 | $0.00 | 55,438 | $21.92 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2013-05-10 | 4,527 | $0.00 | 4,527 | $268.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-12-17 | No | 4 | M | Direct | |
| 4,527 | 2013-11-10 | 2023-05-10 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,536 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 13,378 shares of Company stock on May 13, 2013 at prices ranging from $276.00 to $276.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 13, 2013 at each separate price.
- Represents volume-weighted average price of sales of 9,660 shares of Company stock on May 13, 2013 at prices ranging from $277.00 to $277.9. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 13, 2013 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
